Wednesday, November 9, 2011

Treating Parkinson's with stem cells

Major step in treating Parkinso's with stem cell transformation. Previous difficulties in transforming stem cells into neurons, which are killed off when Parkinson's disease strike. have now beed resolved. Testing on monkeys has shown the cells not only survived and function normally but begin to reverse the process of poor movement problems. Now the prospect of transplanting freshly grown dopamine producing cells into human patients to treat the disease has been significantly raised.
Stem cell therapy may still be some way off. However, this study has shown for the first time that it is possible to transplant nerve cells that work from human stem cells.

Above is part of a story from Digital Journal Nov 7, 2011 by Kev Hedges.

Looks like the market will be down big. Buy a few shares from your wish list. If Geron goes under $2.20 will buy a few $3.00 calls. Not sure what month.

Good luck in this rigged casino,

Sunday, November 6, 2011

Geron silent for?

Geron also my be silent because of something happening with the FDA and must be close to some conclusion, and are in a very sensitive time about any leaked infor.

GRN1005 Phase 1 final results Nov. 14th. If the data from the previously completed Phase 1 trail in metastatic brain cancer are confirmed and depending upon the strength of the data, the product candidate may have an opportunity for early marketing approval.

Something good is in the works. May buy some $3 calls.

Good luck in this rigged casino,

Saturday, November 5, 2011

Geron week in Review

Geron's high for the week was $2.51 on Monday Oct. 31st. The low for the week was $2.21 on Tuesday Nov. 1st. The avg. volume has been going down only 1,189,440 shares for 5 day avg, 3 month is 1,601,150.
Hoping "Chip" the new CEO will work his magic. Thinking of putting a small bet on Chip's ability. May buy a few Jan 12 $3.00 calls. But after losing $600  the last time I bet on good news coming, I'm a little gun shy.

Good luck in this rigged casino,

Friday, November 4, 2011

Patent case against Viacyte

After thinking about the conference call today, the strategic review at the end of this year should move the stock price higher. It was interesting that they keep on saying there would be no comments on forward movement. Why say this? Chip must be working on a deal or deals that will reduce the cash burn with big pharma and not want anyone to say anything to mess it up.
Good news I think in the patent case against on Viacyte. In the latest filing in the case the last paragraph. The parties have been negotiating a settlement. This could be big.

Good luck is this rigged casino,

End of the Year will talk strategist moves

Listened to call today at 9AM. Nothing that will move share price. All Phase II trial are going well. Cash burn rate for this year will be $65 million. They have $185 million in cash. Strategist talk at the end of this year should be move share price, hopefully up.

Good luck in this rigged casino,

Thursday, November 3, 2011

Geron beat by 2 cents

It's not as good as it sounds. Geron lost 16 cent a share in the 3Q, the estimate was for a 18 cents a share lost.  The revenes fell 60% year/year to 0.22 min vs the 0.97 min consensus. I don't understand why this is going down. With the GE and Corning deal I would think revenes would be going up.
I hope "Chip" has some good news Friday at AM.

Good luck in this rigged casino,

Tuesday, November 1, 2011

Geron Q3 Results Nov 4 at 9AM

Quarterly Financial Conference Calls

November 4, 2011, 6:00am PDT / 9:00am EDT

Q3 2011 Financial Results Conference Call, Menlo Park, CA
Please use the following URL to access the webcast: http://www.media-server.com/m/p/2j4c3p37

Look for increase in Revenue Growth it was down 53.80% . Revenue should start climbing with all there deals with GE, Corning ect. Buy on the dips and start the rips up.

Good luck in this rigged casino,